Botevia

Botevia (Bortezomib) is a medication used for intravenous administration, primarily for managing certain types of cancer. This pharmaceutical is manufactured by Innovis Pharma and is available in the EU market.

Botevia (Bortezomib) is commonly used in the treatment of multiple myeloma and mantle cell lymphoma. This medication works by targeting specific proteins in cancer cells, which can help slow down the progression of these diseases. Patients often wonder, 'What is Botevia used for?' and the primary use is in cancer therapy.

Common effects of Botevia (Bortezomib) may include fatigue, nausea, and peripheral neuropathy. Some patients might experience diarrhea or constipation. It's important to monitor these effects and consult a healthcare provider if they become severe or persistent.

Botevia (Bortezomib) should be handled with care, as it is intended for intravenous use only. It is crucial to follow proper administration procedures to avoid complications. Patients with a history of heart or liver problems should discuss this with their healthcare provider before starting treatment.

Botevia (Bortezomib) may interact with other medications, including those that affect the liver or immune system. Alcohol consumption should be avoided, as it can exacerbate side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.